Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 9/20 | 0.53 |
| ▸ | CDC25A | P30304 | 2/20 | 0.53 |
| ▸ | CDC25C | P30307 | 2/20 | 0.53 |
| ▸ | DHODH | Q02127 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | BRAF | P15056 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1963500 | 0.86 | ATM (0.55) | CDC25BCDC25ACDC25CTSHRMAPK10 | |
| SCHEMBL1961347 | 0.84 | AKR1C3 (0.57) | CDC25BCDC25ACDC25CTSHRKMT2A | |
| SCHEMBL1962364 | 0.84 | POLB (0.53) | TSHRMAPK10KMT2ALMNATP53 | |
| SCHEMBL1964221 | 0.83 | ALDH1A1 (0.53) | CDC25BCDC25ACDC25CDHODHKMT2A | |
| SCHEMBL1961719 | 0.83 | CTSV (0.55) | CDC25BCDC25ACDC25CKMT2ALMNA | |
| SCHEMBL1962162 | 0.82 | CDC25B (0.46) | CDC25BCDC25ACDC25CTSHRATM | |
| SCHEMBL1963131 | 0.81 | DHODH (0.52) | CDC25BCDC25ACDC25CDHODHATM | |
| SCHEMBL1961862 | 0.80 | MAPT (0.52) | MAPK10ATMKMT2ARAB9A | |
| SCHEMBL1964589 | 0.80 | CTSV (0.52) | CDC25BCDC25ACDC25CKMT2ALMNA | |
| SCHEMBL1964167 | 0.80 | DHODH (0.48) | CDC25BCDC25ACDC25CDHODHTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1919892-B1 | ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | CELGENE CORP (US) | 2013-08-14 | — | — | EP | disclosed |
| US-8481568-B2 | Isoindole-imide compounds and compositions comprising and methods of using the same | CELGENE CORPORATION (US) | 2013-07-09 | — | — | US | disclosed |
| US-20110144158-A1 | ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | SEPRACOR INC. | 2011-06-16 | — | — | US | disclosed |
| US-20070049618-A1 | Isoindole-imide compounds and compositions comprising and methods of using the same | CELGENE CORPORATION | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144158-A1 | ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | SI, CYP3A5, CYP2D6 | CDC25B 420/4885CDC25A 618/4885CDC25C 223/4885 |
| US-20070049618-A1 | Isoindole-imide compounds and compositions comprising and methods of using the same | SI, CYP3A5, CYP2D6 | CDC25B 420/4885CDC25A 618/4885CDC25C 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.